IDH1 and glioma: ddPCR is also highly sensitive and specific compared to Sanger sequencing as the gold standard for IDH mutation identification in glioma tumor tissue samples, with the ability to detect these IDH mutations with 100% sensitivity and 96% specificity to guide patient diagnosis [53].